SARS-CoV-2–specific B cell detection and therapeutic antibody discovery

SARS-CoV-2–specific B cell detection and therapeutic antibody discovery

About the webinar

To help combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential. 

At Miltenyi Biotec, we have developed reliable tools and methods for analyzing and enriching rare populations of SARS-CoV-2-specific B cells. Tune into this webinar to learn how our products and protocols facilitate COVID-19 research and support the discovery and development of therapeutic antibodies against SARS-CoV-2 and other diseases. 

Learning objectives:

  • Understand how antigen specific lymphocytes work together against SARS-CoV-2 
  • Learn about tools and protocols for monitoring and researching on SARS-CoV-2 specific B cells 
  • Get an overview on the generation of monoclonal antibodies from antigen-specific B cells

Presenter
 

Cristina Conforti Andreoni

2015 till today Global Product Manager and Group Leader  Marketing Immunology, Miltenyi Biotec, Germany   
2013 – 2015 Global Product Manager Cell Culture,  Miltenyi Biotec, Germany    
2011 – 2012 Scientific Officer at Ayoxxa (biotech startup from National University of Singapore)        
2009 – 2011 Postdoctoral Fellow, A-STAR, SIgN, (Singapore)  on dendritic cells and Th17 cells in inflammation   
2006 – 2009 PhD Thesis on dendritic cells and danger signals, University  of Milan-Bicocca, Italy and A-STAR, SIgN Singapore  
2001 – 2006 Bachelor and Master in Medical Biotechnology, University  of Milan-Bicocca, Italy 

Watch the complete webinar for free

Your Miltenyi University benefits

Access online courses anytime, anywhere.

Become an expert in standard and innovative applications.

Acquire broad expertise and a comprehensive skill set.

Let us know your thoughts!

You did not find the course you are looking for? 
Do you have questions or comments? 
Drop us an e-mail!

Seems like you are coming from USA!
Do you want to visit our website in your country?